Download Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Poultry Drugs Market: By Product Type, By Drug Type By Animal Type, and Region Forecast 2020-2031
Poultry Drugs Market: By Product Type, By Drug Type By Animal Type, and Region Forecast 2020-2031
Poultry Drugs Market size was valued at US$ 5,709.6 million in 2024 and is expected to reach US$ 10,985.6 million by 2031, growing at a significant CAGR of 9.8% from 2025-2031. Global market is the chemical substances used to diagnose, treat, prevent, or cure various diseases. Global Poultry drugs are used to prevent or cure various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. The worldwide poultry medicines market is likely to be hampered by low product exclusivity, generic competition, and tight regulations. In the animal healthcare market, product exclusivity lasts only three to five years. Increased competition from generics and over-the-counter (OTC) products occurs from a shorter exclusivity period.
Furthermore, the market's expansion is hampered by strict product approval rules and limited vaccine production. In addition, rising worries about the use of antibiotics and growth boosters in chicken are projected to stifle market expansion. Hormonal components and antibiotics are examples of growth boosters that are commonly employed in food or meat-producing animals, such as chickens. There is significant evidence that poultry antibiotics have a harmful influence on people, including the development of antimicrobial-resistant bacteria and disruption of normal human intestinal flora. Domesticated birds such as ducks, chickens, turkeys, geese, quails, and other birds kept by humans are known as poultry animals. The poultry sector is one of the most rapidly expanding segments of the livestock industry. The report's scope stresses the importance of poultry animal care, for which the veterinarian is a critical link for companies seeking to improve the health and well-being of poultry animals.
Study Period
2025-2031Base Year
2024CAGR
9.8%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Increase in the demand for healthy meat and poultry products, rise in prevalence of various infectious diseases such as avian influenza, rise in R&D activities for the innovation of newer drugs, and increase in animal healthcare expenditure are expected to bolster the poultry drugs market over the forecast period. Moreover, government initiations for protecting the poultry industry, innovation of newer drugs and vaccines, and increase in the number of poultry farms are expected to bolster the global poultry drugs market. However, stringent regulatory guidelines for the product approval, adverse effects associated with drugs, lack of awareness about the poultry diseases in underdeveloped countries, and high R&D expenditure may impede the growth of global market over the forecast years.
Geographically, Global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America poultry drugs market is growing at a significant rate, which is attributed to rise in demand for healthy meat and poultry products, launching of newer products into the market, and increase in awareness about the poultry diseases. Europe market has a lucrative growth owing to rise in prevalence of various diseases such as avian flu, rise in animal welfare expenditure, and increase in the R&D activities for the innovation of newer drugs are bolster the market.
Asia Pacific market is poised to grow at significant rate due to increase in trading of meat and other poultry products from India and China, rise in number of poultry farms, and adoption of newer drugs and vaccines. Latin America market is rising due to positive economic growth, rise in animal welfare expenditure, and launching of newer products by the companies in the region. Middle East and Africa market exhibiting a prominent growth rate owing to expansion of business by the market players, rise in prevalence of infectious diseases, and increase in awareness about poultry diseases are boost the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 5,709.6 million |
|
Market Size in 2031 |
US$ 10,985.6 million |
|
Market CAGR |
9.8% |
|
By Drug Type |
|
|
By Animal Type |
|
|
By Region |
|
Download Free Sample Report
Poultry Drugs Market size was valued at US$ 5,709.6 million in 2024 and is expected to reach US$ 10,985.6 million by 2031, growing at a significant CAGR of 9.8% from 2025-2031
The market key players are: Zoetis (Pfizer, Inc.) (U.S.) Merck & Co. Inc. (U.S) Virbac S.A. (France) Boehringer Ingelheim Vetmedica (Germany) Elanco (U.S.) Bayer Animal Health (Germany) Phibro Animal health Corporation (U.S.) Zydus AHL (India) Ceva Sante Animale (France)
The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Poultry Drugs Market Introduction |
| 2.1.Global Poultry Drugs Market - Taxonomy |
| 2.2.Global Poultry Drugs Market - Definitions |
| 2.2.1.Drug Type |
| 2.2.2.Animal Type |
| 2.2.3.Geography |
| 2.2.4.Region |
| 3. Global Poultry Drugs Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID-19 on Market |
| 4. Global Poultry Drugs Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Poultry Drugs Market By Drug Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Parasiticides |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Antibiotics |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Anti-inflammatory Drugs |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Poultry Drugs Market By Animal Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Turkey |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Chicken |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Goose |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Duck |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Poultry Drugs Market By Geography, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8. Global Poultry Drugs Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Poultry Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Drug Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Parasiticides |
| 9.1.2.Antibiotics |
| 9.1.3.Anti-inflammatory Drugs |
| 9.1.4.Others |
| 9.2. Animal Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Turkey |
| 9.2.2.Chicken |
| 9.2.3.Goose |
| 9.2.4.Duck |
| 9.2.5.Others |
| 9.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.North America |
| 9.3.2.Europe |
| 9.3.3.Asia Pacific |
| 9.3.4.Latin America |
| 9.3.5.Middle East and Africa |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Poultry Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Parasiticides |
| 10.1.2.Antibiotics |
| 10.1.3.Anti-inflammatory Drugs |
| 10.1.4.Others |
| 10.2. Animal Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Turkey |
| 10.2.2.Chicken |
| 10.2.3.Goose |
| 10.2.4.Duck |
| 10.2.5.Others |
| 10.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.North America |
| 10.3.2.Europe |
| 10.3.3.Asia Pacific |
| 10.3.4.Latin America |
| 10.3.5.Middle East and Africa |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Poultry Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Parasiticides |
| 11.1.2.Antibiotics |
| 11.1.3.Anti-inflammatory Drugs |
| 11.1.4.Others |
| 11.2. Animal Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Turkey |
| 11.2.2.Chicken |
| 11.2.3.Goose |
| 11.2.4.Duck |
| 11.2.5.Others |
| 11.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.North America |
| 11.3.2.Europe |
| 11.3.3.Asia Pacific |
| 11.3.4.Latin America |
| 11.3.5.Middle East and Africa |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Poultry Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Parasiticides |
| 12.1.2.Antibiotics |
| 12.1.3.Anti-inflammatory Drugs |
| 12.1.4.Others |
| 12.2. Animal Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Turkey |
| 12.2.2.Chicken |
| 12.2.3.Goose |
| 12.2.4.Duck |
| 12.2.5.Others |
| 12.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.North America |
| 12.3.2.Europe |
| 12.3.3.Asia Pacific |
| 12.3.4.Latin America |
| 12.3.5.Middle East and Africa |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Poultry Drugs Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Drug Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Parasiticides |
| 13.1.2.Antibiotics |
| 13.1.3.Anti-inflammatory Drugs |
| 13.1.4.Others |
| 13.2. Animal Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Turkey |
| 13.2.2.Chicken |
| 13.2.3.Goose |
| 13.2.4.Duck |
| 13.2.5.Others |
| 13.3. Geography Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.North America |
| 13.3.2.Europe |
| 13.3.3.Asia Pacific |
| 13.3.4.Latin America |
| 13.3.5.Middle East and Africa |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 14.2.2.Merck & Co. Inc. (U.S) |
| 14.2.3.Virbac S.A. (France) |
| 14.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 14.2.5.Elanco (U.S.) |
| 14.2.6.Bayer Animal Health (Germany) |
| 14.2.7.Phibro Animal health Corporation (U.S.) |
| 14.2.8.Zydus AHL (India) |
| 14.2.9.Ceva Sante Animale (France) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.